Cited by 637Brain Metastases and TreatmentManagement of metastatic bone diseaseGlioma Diagnosis and Treatment

The DOI matches its Crossref record; 203 of the 203 references it cites were found in a registry or an index.

EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours

Open access

Le Rhun, E., Weller, M., Brandsma, D., Van den Bent, M., de Azambuja, E., Henriksson, R., Boulanger, T., Peters, S., Watts, C., Wick, W., Wesseling, P., Rudà, R., Preusser, M.·2017·Annals of Oncology

DOI 10.1093/annonc/mdx221

Open this paper in CoChat — free account Open PDF

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/annonc/mdx221

Cites

203 of 203 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Borghaei, H., Paz-Ares, L., Horn, L., Spigel, D. R., Steins, M., Ready, N. E., Chow, L. Q., Vokes, E. E., Felip, E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507643 · Cited by 9,335
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Brahmer, J., Reckamp, K. L., Baas, P., Crinò, L., Eberhardt, W. E. E., Poddubskaya, E., Antonia, S., Pluzanski, A., Vokes, E. E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504627 · Cited by 8,447
Pembrolizumab plus chemotherapy in metastatic non–small-cell lung cancer
Gandhi, L., Rodríguez-Abreu, D., Gadgeel, S., Esteban, E., Felip, E., De Angelis, F., Domine, M., Clingan, P., Hochmair, M. J., Powell, S. F., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801005 · Cited by 6,607
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Herbst, R. S., Baas, P., Kim, D.-W., Felip, E., Pérez-Gracia, J. L., Han, J.-Y., Molina, J., Kim, J.-H., Arvis, C. D., Ahn, M.-J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01281-7 · Cited by 6,449
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Rittmeyer, A., Barlési, F., Waterkamp, D., Park, K., Ciardiello, F., von Pawel, J., Gadgeel, S. M., Hida, T., Kowalski, D. M., Cobo, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32517-x · Cited by 4,718
Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer
Shaw, A. T., Kim, D.-W., Nakagawa, K., Seto, T., Crinó, L., Ahn, M.-J., De Pas, T., Besse, B., Solomon, B. J., Blackhall, F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214886 · Cited by 3,381
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
Mok, T. S., Wu, Y.-L., Ahn, M.-J., Garassino, M. C., Kim, H. R., Ramalingam, S. S., Shepherd, F. A., He, Y., Akamatsu, H., Theelen, W. S. M. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612674 · Cited by 3,379
A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain
Patchell, R. A., Tibbs, P. A., Walsh, J. W., Dempsey, R. J., Maruyama, Y., Kryscio, R. J., Markesbery, W. R., Macdonald, J. S., & Young, B. A. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002223220802 · Cited by 3,138
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
Andrews, D. W., Scott, C., Sperduto, P. W., Flanders, A. E., Gaspar, L. E., Schell, M. C., Werner‐Wasik, M., Demas, W. F., Ryu, J. K., Bahary, J.-P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16250-8 · Cited by 2,418
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
Köcher, M., Soffietti, R., Abacıoğlu, U., Villà, S., Fauchon, F., Baumert, B. G., Fariselli, L., Tzuk-Shina, T., Kortmann, R., Carrié, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1655 · Cited by 1,988
Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.
Patchell, R. A., Tibbs, P. A., Regine, W. F., Dempsey, R. J., Mohiuddin, M., Kryscio, R. J., Markesbery, W. R., Foon, K. A., & Young, B. A. (1998) · PubMed · doi:10.1001/jama.280.17.1485 · Cited by 1,913
Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission
Auperin, A., Arriagada, R., Pignon, J., Pechoux, C. L., Gregor, A., Stephens, R. J., Kristjansen, P. E. G., Johnson, B. E., Ueoka, H., Wagner, H., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410703 · Cited by 1,716
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Tawbi, H. A., Forsyth, P. A., Algazi, A. P., Hamid, O., Hodi, F. S., Moschos, S. J., Khushalani, N. I., Lewis, K. D., Lao, C. D., Postow, M. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805453 · Cited by 1,336
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial
Brown, P. D., Ballman, K. V., Cerhan, J. H., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30441-2 · Cited by 1,220
Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer
Slotman, B. J., Finn, C. F., Kramer, G. W. P. M., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071780 · Cited by 1,142
Response assessment criteria for brain metastases: proposal from the RANO group
Lin, N., Lee, E. Q., Aoyama, H., Barani, I. J., Barboriak, D. P., Baumert, B. G., Bendszus, M., Brown, P. D., Camidge, D. R., Chang, S. M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70057-4 · Cited by 1,099
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
Margolin, K., Ernstoff, M. S., Hamid, O., Lawrence, D., McDermott, D., Puzanov, I., Wolchok, J. D., Clark, J. I., Sznol, M., Logan, T. F., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70090-6 · Cited by 1,091
Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery
Vecht, C. J., Haaxma-Reiche, H., Noordijk, E. M., Padberg, G. W., Voormolen, J. H. C., Hoekstra, F. H., Tans, J. T. J., Lambooy, N., Metsaars, J. A. L., Wattendorff, A. R., et al. (1993) · Annals of Neurology · doi:10.1002/ana.410330605 · Cited by 1,050
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
Goldberg, S. B., Gettinger, S. N., Mahajan, A. K., Chiang, A. C., Herbst, R. S., Sznol, M., Tsiouris, A. J., Cohen, J. V., Vortmeyer, A. O., Jilaveanu, L. B., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30053-5 · Cited by 1,003
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
Long, G. V., Atkinson, V. G., Lo, S., Sandhu, S. K., Guminski, A. D., Brown, M. P., Wilmott, J. S., Edwards, J. J., Gonzalez, M., Scolyer, R. A., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30139-6 · Cited by 1,001
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)
Barlési, F., Mazières, J., Merlio, J., Debieuvre, D., Mosser, J., Léna, H., Ouafik, L., Besse, B., Rouquette, I., Westeel, V., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00004-0 · Cited by 1,000
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
Brown, P. D., Pugh, S., Laack, N. N., Wefel, J. S., Khuntia, D., Meyers, C., Choucair, A. K., Fox, S., Suh, J. H., Roberge, D., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not114 · Cited by 964
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
Long, G. V., Trefzer, U., Davies, M. A., Kefford, R. F., Ascierto, P. A., Chapman, P. B., Puzanov, I. J., Hauschild, A., Robert, C., Algazi, A. P., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70431-x · Cited by 932
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study
Cagney, D. N., Martin, A. M., Catalano, P. J., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox077 · Cited by 870
Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial
Mahajan, A., Ahmed, S., McAleer, M. F., Weinberg, J. S., Li, J., Brown, P. D., Settle, S. H., Prabhu, S. S., Lang, F. F., Levine, N. B., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30414-x · Cited by 801
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Okada, H., Weller, M., Huang, R. Y., Finocchiaro, G., Gilbert, M. R., Wick, W., Ellingson, B. M., Hashimoto, N., Pollack, I. F., Brandes, A. A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00088-1 · Cited by 794
Self-citation
Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial
Davies, M. A., Saïag, P., Robert, C., Grob, J., Flaherty, K. T., Arance, A. M., Chiarion‐Sileni, V., Thomas, L., Lesimple, T., Mortier, L., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30429-1 · Cited by 789
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
Bachelot, T., Romieu, G., Campone, M., Dieras, V. C., Cropet, C., Dalenc, F., Jimenez, M., Rhun, É. L., Pierga, J., Gonçalvès, A., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70432-1 · Cited by 743
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
Albert, N. L., Weller, M., Suchorska, B., Galldiks, N., Soffietti, R., Kim, M. M., la Fougère, C. J., Pope, W. B., Law, I. G., Arbizu, J., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now058 · Cited by 743
Self-citation
Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous System
Levin, V. A., Bidaut, L. M., Hou, P., Kumar, A. J., Wefel, J. S., Bekele, B. N., Prabhu, S. S., Loghin, M. E., Gilbert, M. R., & Jackson, E. F. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.12.061 · Cited by 731
Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
Mulvenna, P., Nankivell, M. G., Barton, R., Finn, C. F., Wilson, P., McColl, E., MOORE, B. J., Brisbane, I., Ardron, D., Holt, T., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30825-x · Cited by 723
Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
Lin, N., Dieras, V. C., Paul, D., Lossignol, D., Christodoulou, C., Stemmler, H., Roche, H. H., Liu, M., Greil, R., Ciruelos, E., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1080 · Cited by 660
Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients
Dykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 637
Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial
Takahashi, T., Yamanaka, T., Seto, T., Harada, H., Nokihara, H., Saka, H., Nishio, M., Kaneda, H., Takayama, K., Ishimoto, O., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30230-9 · Cited by 551
A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
Glantz, M., Jaeckle, K. A., Chamberlain, M. C., Phuphanich, S., Recht, L. D., Swinnen, L. J., Maria, B., LaFollette, S., Schumann, G. B., Cole, B. F., et al. (1999) · PubMed · Cited by 529
CSF, blood-brain barrier, and brain drug delivery
Pardridge, W. M. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1171315 · Cited by 508
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)
Soffietti, R., Abacıoğlu, U., Baumert, B. G., Combs, S. E., Kinhult, S., Kros, J. M., Marosi, C., Métellus, P., Radbruch, A., Villà, S., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now241 · Cited by 500
Self-citation
Management of Brain Metastases in Tyrosine Kinase Inhibitor–Naïve Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis
Magnuson, W. J., Lester-Coll, N. H., Wu, A. J.-C., Yang, J. T., Lockney, N. A., Gerber, N. K., Beal, K. P., Amini, A., Patil, T., Kavanagh, B. D., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.7144 · Cited by 462
Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
Lin, N., Carey, L., Liu, M., Younger, J., Come, S. E., Ewend, M. G., Harris, G. J., Bullitt, E., den Abbeele, A. D. V., Henson, J. W., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3588 · Cited by 456
Leptomeningeal metastases in the MRI era
Clarke, J. L., Perez, H. R., Jacks, L. M., Panageas, K. S., & DeAngelis, L. M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dc1a69 · Cited by 431
Phase 3 Trials of Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for 1 to 4 Brain Metastases: Individual Patient Data Meta-Analysis
Sahgal, A., Aoyama, H., Köcher, M., Neupane, B., Collette, S., Tago, M., Shaw, P., Beyene, J., & Chang, E. L. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.10.024 · Cited by 421
Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis
Freilich, R. J., Krol, G. S., & DeAngelis, L. M. (1995) · Annals of Neurology · doi:10.1002/ana.410380111 · Cited by 417
Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA
Krop, I. E., Lin, N., Blackwell, K., Guardino, E., Huober, J., Lu, M., Miles, D. W., Samant, M. K., Welslau, M., & Dieras, V. C. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu486 · Cited by 396
Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from registHER
Brufsky, A., Mayer, M., Rugo, H. S., Kaufman, P. A., Tan-Chiu, E., Tripathy, D., Tudor, I. C., Wang, L. I., Brammer, M. G., Shing, M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2962 · Cited by 389
Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations 2004*
Brainin, M., Barnes, M., Baron, J., Ne, G., Hughes, R. A., Selmaj, K. W., & Waldemar, G. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00867.x · Cited by 373
Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.
Grossman, S. A., Finkelstein, D. M., Ruckdeschel, J. C., Trump, D. L., Moynihan, T. J., & Ettinger, D. S. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.561 · Cited by 364
A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis.
HITCHINS, R. N., Bell, D. R., Woods, R., & Levi, J. A. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.10.1655 · Cited by 352
High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?
Glantz, M., Cole, B. F., Recht, L. D., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1561 · Cited by 323
Leptomeningeal metastases: a RANO proposal for response criteria
Chamberlain, M. C., Junck, L., Brandsma, D., Soffietti, R., Rudà, R., Raizer, J. J., Boogerd, W. J., Taillibert, S., Groves, M. D., Rhun, É. L., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now183 · Cited by 322
Self-citation
European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma
Pace, A., Dirven, L., Koekkoek, J. A. F., Golla, H., Fleming, J., Rudà, R., Marosi, C., Rhun, É. L., Grant, R., Oliver, K. R., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30345-5 · Cited by 305
Self-citation
Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study
Dummer, R., Goldinger, S. M., Turtschi, C. P., Eggmann, N., Michielin, O. A., Mitchell, L., Véronèse, L., Hilfiker, P. R., Felderer, L., & Rinderknecht, J. D. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.11.002 · Cited by 294
The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study
Boogerd, W. J., van den Bent, M. J., Koehler, P. J., Heimans, J. J., van der Sande, J. J., Aaronson, N. K., Hart, A. A. M., Benraadt, J., & Vecht, C. J. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.08.012 · Cited by 287
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer
Togashi, Y., Masago, K., Masuda, S., Mizuno, T., Fukudo, M., Ikemi, Y., Sakamori, Y., Nagai, H., Kim, Y. H., Katsura, T., et al. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-1929-4 · Cited by 282
Leptomeningeal Metastasis from Non-small Cell Lung Cancer: Survival and the Impact of Whole Brain Radiotherapy
Morris, P. G., Reiner, A. S., Thon, O. R., Clarke, J. L., Panageas, K. S., Perez, H. R., Kris, M. G., Chan, T. A.-T., DeAngelis, L. M., & Omuro, A. M. P. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182398e4f · Cited by 277
Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations 2012
Leone, M. A., Brainin, M., Boon, P., Pugliatti, M., Keindl, M., & Bassetti, C. L. (2013) · European Journal of Neurology · doi:10.1111/ene.12043 · Cited by 277
Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non–Small-Cell Lung Cancer: Results From PROFILE 1014
Solomon, B., Cappuzzo, F., Felip, E., Blackhall, F. H., Costa, D. B., Kim, D., Nakagawa, K., Wu, Y.-L. L. C., Mekhail, T. M., Paolini, J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.5888 · Cited by 267
Single versus Multifraction Stereotactic Radiosurgery for Large Brain Metastases: An International Meta-analysis of 24 Trials
Lehrer, E. J., Peterson, J., Zaorsky, N. G., Brown, P. D., Sahgal, A., Chiang, V., Chao, S. T., Sheehan, J. P., & Trifiletti, D. M. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.10.038 · Cited by 261
Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal Disease
Hoffknecht, P., Tufman, A., Wehler, T., Pelzer, T., Wiewrodt, R. G., Schütz, M., Serke, M. H., Stöhlmacher-Williams, J., Märten, A., Huber, R. M., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000380 · Cited by 259
Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study
McArthur, G. A., Maio, M., Arance, A. M., Nathan, P., Blank, C. U., Avril, M.-F., Garbe, C., Hauschild, A., Schadendorf, D., Hamid, O., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw641 · Cited by 253
A Multi-institutional Prospective Observational Study of Stereotactic Radiosurgery for Patients With Multiple Brain Metastases (JLGK0901 Study Update): Irradiation-related Complications and Long-term Maintenance of Mini-Mental State Examination Scores
Yamamoto, M., Serizawa, T., Higuchi, Y., Sato, Y., Kawagishi, J., Yamanaka, K., Shuto, T., Akabane, A., Jokura, H., Yomo, S., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.04.037 · Cited by 252
The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis
Straathof, C. S. M., de Bruin, H. G., Dippel, D. W. J., & Vecht, C. J. (1999) · Journal of Neurology · doi:10.1007/s004150050459 · Cited by 251
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria
Nayak, L., DeAngelis, L. M., Brandes, A. A., Peereboom, D. M., Galanis, E., Lin, N., Soffietti, R., Macdonald, D. R., Chamberlain, M. C., Perry, J., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox029 · Cited by 248
CEREBEL (EGF111438): a phase III, randomized, open-label study of lapatinib plus capecitabine versus trastuzumab plus capecitabine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
Pivot, X., Manikhas, A., Żurawski, B., Chmielowska, E., Karaszewska, B., Allerton, R., Chan, S., Fabi, A., Bidoli, P., Gori, S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.1794 · Cited by 242
A meta‐analysis evaluating stereotactic radiosurgery, whole‐brain radiotherapy, or both for patients presenting with a limited number of brain metastases
Tsao, M. N., Xu, W., & Sahgal, A. (2011) · Cancer · doi:10.1002/cncr.26515 · Cited by 242
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA
Swain, S. M., Baselga, J., Miles, D. W., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu133 · Cited by 235
Bevacizumab in Patients with Nonsquamous Non–Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study
Besse, B., Moulec, S. L., Mazières, J., Senellart, H., Barlési, F., CHOUAID, C., Dansin, É., Berard, H., Falchero, L., Gervais, R., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2082 · Cited by 227
Carcinoma of the nasopharynx.Eighteen years' experience with megavoltage radiation therapy
Hoppe, R. T., Goffinet, D. R., & Bagshaw, M. A. (1976) · Cancer · doi:10.1002/1097-0142(197606)37:6 · Cited by 224
Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow Cytometry
Quijano, S., López, A., Sancho, J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.7089 · Cited by 216
Reduced local recurrence of a single brain metastasis through microscopic total resection
Yoo, H., Kim, Y. Z., Nam, B. H., et al. (2008) · Journal of neurosurgery · doi:10.3171/2008.8.jns08448 · Cited by 202
Targeting brain metastases in ALK-rearranged non-small-cell lung cancer
Zhang, I., Zaorsky, N. G., Palmer, J. D., Mehra, R., & Lu, J. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00013-3 · Cited by 195
Leptomeningeal Carcinomatosis in Non–Small-Cell Lung Cancer Patients: Impact on Survival and Correlated Prognostic Factors
Lee, S. J., Lee, J.-I., Nam, D., Ahn, Y. C., Han, J. H., Sun, J., Ahn, J. S., Park, K., & Ahn, M. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182773f21 · Cited by 194
Survival of breast cancer patients with meningeal carcinomatosis
Gauthier, H., Guilhaume, M. N., Bidard, F., Pierga, J., Girre, V., Cottu, P. H., Laurence, V., Livartowski, A., Mignot, L., & Dieras, V. C. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq232 · Cited by 184
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non–Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
Liao, B.-C., Lee, J., Lin, C., Chen, Y., Chang, C., Ho, C., Shih, J., Yu, C., & Yang, J. C. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000669 · Cited by 184
Frequent EGFR mutations in brain metastases of lung adenocarcinoma
Matsumoto, S., Takahashi, K., Iwakawa, R., Matsuno, Y., Nakanishi, Y., Kohno, T., Shimizu, E., & Yokota, J. (2006) · International Journal of Cancer · doi:10.1002/ijc.21940 · Cited by 181
Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial
For The RDOG5 Investigators, Pisano, E. D., Fajardo, L. L., Tsimikas, J., Sneige, N., Frable, W. J., Gatsonis, C. A., Evans, W. P., Tocino, I. M., & McNeil, B. J. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980215)82:4 · Cited by 175
Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study
Gadgeel, S. M., Lukas, R. V., Goldschmidt, J. H., Conkling, P., Park, K., Cortinovis, D. L., de Marinis, F., Rittmeyer, A., Patel, J. D., von Pawel, J., et al. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.12.017 · Cited by 175
The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis.
Yuh, W. T. C., Talı, E. T., Nguyen, H. D., et al. (1995) · PubMed · Cited by 173
Antiepileptic drugs for preventing seizures in people with brain tumors
Tremont‐Lukats, I. W., Ratilal, B. O., Armstrong, T. S., et al. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004424.pub2 · Cited by 172
Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era
Park, J. H., Kim, Y. J., Lee, J., Lee, K., Kim, J. H., Bang, S., Chung, J.-H., Js, K., & Lee, J. S. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.11.022 · Cited by 170
Epilepsy meets cancer: when, why, and what to do about it?
Weller, M., Stupp, R., & Wick, W. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70266-8 · Cited by 167
Self-citation
Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations
Iuchi, T., Shingyoji, M., Itakura, M., Yokoi, S., Moriya, Y., Tamura, H., Yoshida, Y., Ashinuma, H., Kawasaki, K., Hasegawa, Y., et al. (2015) · International Journal of Clinical Oncology · doi:10.1007/s10147-014-0760-9 · Cited by 165
Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine
Metro, G., Foglietta, J., Russillo, M., Stocchi, L., Vidiri, A., Giannarelli, D., Crinò, L., Papaldo, P., Mottolese, M., Cognetti, F., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq434 · Cited by 164
Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials
Chamberlain, M., Soffietti, R., Raizer, J. J., Rudà, R., Brandsma, D., Boogerd, W. J., Taillibert, S., Groves, M. D., Rhun, É. L., Junck, L., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou089 · Cited by 163
Self-citation
Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis
Grossman, S. A., Trump, D. L., Chen, D. C. P., et al. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90404-1 · Cited by 161
Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG)
Anker, C. J., Grossmann, K. F., Atkins, M. B., Suneja, G., Tarhini, A. A., & Kirkwood, J. M. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.01.038 · Cited by 161
Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis
Chuang, M., Liu, Y., Tsai, Y., Chen, Y.-C., & Wang, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0141438 · Cited by 158
COMPARATIVE RISK OF LEPTOMENINGEAL DISSEMINATION OF CANCER AFTER SURGERY OR STEREOTACTIC RADIOSURGERY FOR A SINGLE SUPRATENTORIAL SOLID TUMOR METASTASIS
Suki, D., Hatiboğlu, M. A., Patel, A. J., et al. (2009) · Neurosurgery · doi:10.1227/01.neu.0000341535.53720.3e · Cited by 153
Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy.
Bokstein, F., Lossos, A., & Siegal, T. (1998) · PubMed · Cited by 153
Leptomeningeal metastasis: Clinical experience of 519 cases
Hyun, J., Jeong, I. H., Joung, A., Cho, H. J., Kim, S., & Kim, H. J. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.12.021 · Cited by 153
MR imaging of leptomeningeal metastases: comparison of three sequences.
Singh, S. K., Leeds, N. E., & Ginsberg, L. E. (2002) · PubMed · Cited by 150
Prognostic significance of sup 111 Indium-DTPA CSF flow studies in leptomeningeal metastases
Chamberlain, M. C., & Kormanik, P. A. (1996) · Neurology · doi:10.1212/wnl.46.6.1674 · Cited by 148
Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases
Seoane, J., Mattos‐Arruda, L. D., Rhun, É. L., Bardelli, A., & Weller, M. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy544 · Cited by 148
Self-citation
Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases
Zimmermann, S., Dziadziuszko, R., & Peters, S. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.03.005 · Cited by 147
Self-citation
Breast cancer leptomeningeal metastasis—the role of multimodality treatment
Rudnicka, H., Niwińska, A., & Murawska, M. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9340-4 · Cited by 141
Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases – the UK experience
Sutherland, S., Ashley, S. E., Miles, D. W., Chan, S. Y. T., Wardley, A. M., Davidson, N. G. P., Bhatti, R., Shehata, M., Nouras, H., Camburn, T., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605586 · Cited by 140
Meningeal carcinomatosis in breast cancer: prognostic factors and outcome
de Azevedo, C. R. A. S., Cruz, M. R. S., Chinen, L. T. D., Peres, S. V., Peterlevitz, M. A., Pereira, A. E. D. A., Fanelli, M. F., & Gimenes, D. L. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0524-y · Cited by 138
Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery
Johnson, M. D., Avkshtol, V., Baschnagel, A. M., Meyer, K., Ye, H., Grills, I. S., Chen, P. Y., Maitz, A. H., Olson, R. E., Pieper, D. R., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.11.022 · Cited by 138
Impact of surgical methodology on the complication rate and functional outcome of patients with a single brain metastasis
Patel, A. J., Suki, D., Hatiboğlu, M. A., et al. (2015) · Journal of neurosurgery · doi:10.3171/2014.9.jns13939 · Cited by 137
Prognostic factors and outcomes in patients with leptomeningeal melanomatosis
Harstad, L., Hess, K. R., & Groves, M. D. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-062 · Cited by 136
The Central Nervous System as a Sanctuary Site in ALK-Positive Non–Small-Cell Lung Cancer
Gainor, J. F., Ou, S. I., Logan, J. K., Borges, L. F., & Shaw, A. T. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000029 · Cited by 135
Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis
Zagouri, F., Sergentanis, T. Ν., Bartsch, R., Berghoff, A. S., Chrysikos, D., de Azambuja, E., Dimopoulos, M. A., & Preusser, M. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2525-y · Cited by 133
Self-citation
Treatment and survival of patients with EGFR -mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis
Kuiper, J. L., Hendriks, L. E. L., van der Wekken, A. J., de Langen, A. J., Bahce, I., Thunnissen, E., Heideman, D. A. M., Berk, Y., Buijs, E. J. M., Speel, E. M., et al. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.05.023 · Cited by 133
DynamicO-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy
Ceccon, G. S., Lohmann, P., Stoffels, G., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now149 · Cited by 132
Radioisotope CSF flow studies in leptomeningeal metastases
Chamberlain, M. C. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005982826121 · Cited by 128
Systemic high-dose intravenous methotrexate for central nervous system metastases
Lassman, A. B., Abrey, L. E., Shah, G. G., Panageas, K. S., Begemann, M., Malkin, M. G., & Raizer, J. J. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-9044-6 · Cited by 124
Multifocal vulvar intraepithelial neoplasia grade III and multicentric lower genital tract neoplasia is associated with transcriptionally active human papillomavirus
van Beurden, M., Kate, F. J. W. T., Smits, H. L., Berkhout, R. J. M., de Craen, A. J. M., van der Vange, N., Lammes, F. B., & ter Schegget, J. (1995) · Cancer · doi:10.1002/1097-0142(19950615)75:12 · Cited by 123
Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group
Umemura, S., Tsubouchi, K., Yoshioka, H., Hotta, K., Takigawa, N., Fujiwara, K., Horita, N., Segawa, Y., Hamada, N., Takata, I., et al. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.03.002 · Cited by 122
Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non–Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study
Ruysscher, D. D., Dingemans, A. C., Praag, J. O., Belderbos, J. S. A., Tissing-Tan, C. J. A., Herder, J., Haitjema, T. J., Ubbels, F. J. F., Lagerwaard, F. J., Sharouni, S. Y. E., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.5817 · Cited by 122
Activity of T-DM1 in Her2-positive breast cancer brain metastases
Bartsch, R., Berghoff, A. S., Vogl, U. M., Rudas, M., Bergen, E. S., Dubsky, P. C., Dieckmann, K. U., Pinker, K., Bagó-Horváth, Z., Galid, A., et al. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9740-3 · Cited by 119
Self-citation
A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer
Rhun, É. L., Taillibert, S., Zaïri, F., Kotecki, N., Devos, P., Mailliez, A., Servent, V., Vanlemmens, L., Vennin, P., Boulanger, T., et al. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1092-8 · Cited by 119
Self-citation
Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis.
Oechsle, K., Lange-Brock, V., Kruell, A., Bokemeyer, C., & de Wit, M. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0831-x · Cited by 119
Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival
Niwińska, A., Rudnicka, H., & Murawska, M. (2013) · Medical Oncology · doi:10.1007/s12032-012-0408-4 · Cited by 118
Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single‐arm study
Pan, Z., Yang, G., He, H., Zhao, G., Yuan, T., Li, Y., Shi, W., Gao, P., Dong, L., & Li, Y. (2016) · International Journal of Cancer · doi:10.1002/ijc.30214 · Cited by 116
Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases
Jacot, W., Tostivint, E. P., Frenel, J., Guiu, S., Lévy, C., Heudel, P., Bachelot, T., D’Hondt, V., Darlix, A., Firmin, N., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3828-6 · Cited by 115
Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection
Ahn, J. H., Lee, S. H., Kim, S., Joo, J., Yoo, H., Lee, S., Shin, S. H., & Gwak, H. (2012) · Journal of neurosurgery · doi:10.3171/2012.1.jns111560 · Cited by 113
Primary Melanocytic Tumors of the Central Nervous System: a Review with Focus on Molecular Aspects
Küsters-Vandevelde, H., Küsters, B., Grunsven, A. V. E. V. E.-V., Groenen, P. J. T. A., Wesseling, P., & Blokx, W. (2015) · Brain Pathology · doi:10.1111/bpa.12241 · Cited by 113
Self-citation
Diffuse involvement of the leptomeninges by tumour--a clinical and pathological study of 63 cases
Boyle, R., Thomas, M., & Adams, J. H. (1980) · Postgraduate Medical Journal · doi:10.1136/pgmj.56.653.149 · Cited by 111
Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis
Glantz, M., Horn, A. V., Fisher, R., & Chamberlain, M. C. (2010) · Cancer · doi:10.1002/cncr.24921 · Cited by 110
Analysis of Treatment Outcomes of Intraventricular Chemotherapy in 105 Patients for Leptomeningeal Carcinomatosis from Non–Small-Cell Lung Cancer
Gwak, H., Joo, J., Kim, S., Yoo, H., Shin, S. H., Han, J., Kim, H. T., Lee, J. S., & Lee, S. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318287c943 · Cited by 106
Intracerebral efficacy and tolerance of nivolumab in non–small-cell lung cancer patients with brain metastases
Gauvain, C., Vauléon, E., CHOUAID, C., Rhun, É. L., Jabot, L., Scherpereel, A., Vinas, F., Cortot, A. B., & Monnet, I. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.12.008 · Cited by 105
3D Turbo Spin-Echo Sequence with Motion-Sensitized Driven-Equilibrium Preparation for Detection of Brain Metastases on 3T MR Imaging
Nagao, E., Yoshiura, T., Hiwatashi, A., et al. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2343 · Cited by 104
Leptomeningeal disease and breast cancer: the importance of tumor subtype
Abouharb, S., Ensor, J., Loghin, M. E., Katz, R. L., Moulder, S. L., Esteva, F. J., Smith, B. D., Valero, V., Hortobágyi, G. N., & Melhem‐Bertrandt, A. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3054-z · Cited by 104
A Phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer
Jackman, D. M., Cioffredi, L. A., Jacobs, L., Sharmeen, F., Morse, L. K., Lucca, J. V., Plotkin, S. R., Marcoux, P. J., Rabin, M. S., Lynch, T. J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2886 · Cited by 101
Intracranial Leptomeningeal Metastases: Comparison of Depiction at FLAIR and Contrast-enhanced MR Imaging
Singh, S. K., Agris, J. M., Leeds, N. E., & Ginsberg, L. E. (2000) · Radiology · doi:10.1148/radiology.217.1.r00oc3550 · Cited by 101
Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases
Li, Y., Pan, W., Connolly, I. D., Reddy, S. A., Nagpal, S., Quake, S. R., & Gephart, M. H. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2081-5 · Cited by 97
Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases
Patel, A. S., Allen, J. E., Dicker, D. T., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.336 · Cited by 95
Osimertinib activity in patients (pts) with leptomeningeal (LM) disease from non-small cell lung cancer (NSCLC): Updated results from BLOOM, a phase I study.
Yang, J. C., Kim, D., Kim, S., Cho, B. C., Lee, J.-S., Ye, X., Yin, X., Yang, Z., Jiang, H., & Ahn, M. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.9002 · Cited by 95
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies
Toi, M., Iwata, H., Fujiwara, Y., Ito, Y., Nakamura, S., Tokuda, Y., Taguchi, T., Rai, Y., Aogi, K., Arai, T., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605343 · Cited by 93
Leptomeningeal metastasis after surgical resection of brain metastases
van der Ree, T. C., Dippel, D. W. J., Avezaat, C. J. J., et al. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.225 · Cited by 89
Targeted treatment and immunotherapy in leptomeningeal metastases from melanoma
Foppen, M. H. G., Brandsma, D., Blank, C. U., van Thienen, J. V., Haanen, J. B. A. G., & Boogerd, W. J. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw134 · Cited by 89
Self-citation
Leptomeningeal metastases: Rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy?
Siegal, T. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005999228846 · Cited by 86
Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations
Lee, S. H., Ahn, H. K., Park, Y. H., Nam, D. H., Lee, J. I., Park, W., Choi, D. H., Huh, S. J., Park, K. T., Ahn, J. S., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1682-0 · Cited by 86
Comparison of cisternal and lumbar CSF examination in leptomeningeal metastasis
Rogers, L. R., Duchesneau, P. M., Nuñez, C., et al. (1992) · Neurology · doi:10.1212/wnl.42.6.1239 · Cited by 83
Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment
Kim, H.-J., Im, S., Keam, B., Kim, Y.-J., Han, S., Kim, T. M., Oh, D., Kim, J. H., Lee, S., Chie, E. K., et al. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0664-8 · Cited by 82
Fluorescein sodium-guided resection of cerebral metastases—an update
Höhne, J., Hohenberger, C., Proescholdt, M. A., et al. (2016) · Acta Neurochirurgica · doi:10.1007/s00701-016-3054-3 · Cited by 80
Neoplastic meningitis following surgical resection of isolated cerebellar metastasis: A potentially preventable complication
Norris, L. K., Grossman, S. A., & Olivi, A. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005723801479 · Cited by 77
High-dose erlotinib for refractory leptomeningeal metastases after failure of standard-dose EGFR-TKIs
Kawamura, T., Hata, A., Takeshita, J., Fujita, S., Hayashi, M., Tomii, K., & Katakami, N. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2759-y · Cited by 77
Ventricular entry during resection of malignant gliomas: effect on intracranial cerebrospinal fluid tumor dissemination
Elliott, J. P., Keles, G. E., Waite, M. D., et al. (1994) · Journal of neurosurgery · doi:10.3171/jns.1994.80.5.0834 · Cited by 77
Prolonged Survival of Patients With Non–Small-Cell Lung Cancer With Leptomeningeal Carcinomatosis in the Modern Treatment Era
Riess, J. W., Nagpal, S., Iv, M., Zeineh, M., Gubens, M. A., Ramchandran, K. J., Neal, J. W., & Wakelee, H. A. (2014) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.12.009 · Cited by 77
EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors
Kerklaan, B. M., Pluim, D., Bol, M., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov273 · Cited by 74
A standardized protocol for flow cytometric analysis of cells isolated from cerebrospinal fluid
Dux, R., Kindler‐Röhrborn, A., Annas, M., et al. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90159-7 · Cited by 73
Quality‐of‐life–adjusted survival comparison of sustained‐release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis
Cole, B. F., Glantz, M., Jaeckle, K. A., et al. (2003) · Cancer · doi:10.1002/cncr.11449 · Cited by 73
Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer
Lee, J. S., Melisko, M., Magbanua, M. J. M., Kablanian, A., Scott, J. H., Rugo, H. S., & Park, J. W. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3610-1 · Cited by 72
Extended Survival in Women With Brain Metastases From HER2 Overexpressing Breast Cancer
Church, D. N., Modgil, R., Guglani, S., et al. (2008) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31815a43c4 · Cited by 72
The detectability of brain metastases using contrast-enhanced spin-echo or gradient-echo images: a systematic review and meta-analysis
Suh, C. H., Jung, S. C., Kim, K. W., et al. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2185-y · Cited by 71
Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value
Herrlinger, U., Wiendl, H., Renninger, M., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601953 · Cited by 70
Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe
Rhun, É. L., Rudà, R., Devos, P., Hoang‐Xuan, K., Brandsma, D., Segura, P. P., Soffietti, R., & Weller, M. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2452-6 · Cited by 70
Self-citation
Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis
Rhun, É. L., Massin, F., Tu, Q., Bonneterre, J. M., Bittencourt, M. D. C., & Faure, G. C. (2012) · BMC Clinical Pathology · doi:10.1186/1472-6890-12-21 · Cited by 69
A randomized phase III/IV study to determine benefit and safety of cytarabine liposome injection for treatment of neoplastic meningitis
Shapiro, W. R., Schmid, M., Glantz, M., & Miller, J. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.1528 · Cited by 68
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
Wu, P.-F., Lin, C., Kuo, C., Chen, T. W., Yeh, D., Liao, H., Huang, S.-M., Cheng, A., & Lu, Y. (2015) · BMC Cancer · doi:10.1186/s12885-015-1290-1 · Cited by 67
Pemetrexed plus platinum as the first-line treatment option for advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials
Li, M., Zhang, Q., Fu, P., Li, P., Peng, A., Zhang, G., Song, X., Tan, M., Li, X., Liu, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037229 · Cited by 67
Breast Cancer Leptomeningeal Metastasis: The Results of Combined Treatment and the Comparison of Methotrexate and Liposomal Cytarabine As Intra–Cerebrospinal Fluid Chemotherapy
Niwińska, A., Rudnicka, H., & Murawska, M. (2014) · Clinical Breast Cancer · doi:10.1016/j.clbc.2014.07.004 · Cited by 66
Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis
Yust‐Katz, S., Garciarena, P., Liu, D., Yuan, Y., Ibrahim, N., Yerushalmi, R., Peñas-Prado, M., & Groves, M. D. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1175-6 · Cited by 64
Diagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosis
Subirá, D., Simó, M., Illán, J., et al. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9716-3 · Cited by 62
Clinical improvement and survival in breast cancer leptomeningeal metastasis correlate with the cytologic response to intrathecal chemotherapy
Clatot, F., Philippin-Lauridant, G., Ouvrier, M.-J., Nakry, T., Laberge, S., Guillemet, C., Veyret, C., & Blot, E. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9940-2 · Cited by 61
Functional approach using intraoperative brain mapping and neurophysiological monitoring for the surgical treatment of brain metastases in the central region
Sanmillán, J. L., Coello, A. F., Fernández-Conejero, I., et al. (2016) · Journal of neurosurgery · doi:10.3171/2016.2.jns152855 · Cited by 61
Clinical follow‐up indicates differential accuracy of magnetic resonance imaging and immunocytology of the cerebral spinal fluid for the diagnosis of neoplastic meningitis – a single centre experience
Zeiser, R., Burger, J. A. C. M., Bley, T. A., et al. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04853.x · Cited by 59
Incidence of local in-brain progression after supramarginal resection of cerebral metastases
Kamp, M. A., Rapp, M., Slotty, P. J., et al. (2015) · Acta Neurochirurgica · doi:10.1007/s00701-015-2405-9 · Cited by 59
Clinical Features and Prognostic Factors in Patients with Carcinomatous Meningitis Secondary to Breast Cancer
Lara-Medina, F. U., Crismatt, A., Villarreal-Garza, C. M., Alvarado‐Miranda, A., Flores‐Hernández, L., González-Pinedo, M., Gamboa-Vignolle, C., Ruiz-González, J. D. S., & Arrieta, O. G. (2012) · The Breast Journal · doi:10.1111/j.1524-4741.2012.01228.x · Cited by 56
Intrathecal administration of topotecan in nonhuman primates
Blaney, S. M., Cole, D. E., Godwin, K., et al. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689195 · Cited by 54
Sensitive Detection of EGFR Mutations in Cerebrospinal Fluid from Lung Adenocarcinoma Patients with Brain Metastases
Yang, H., Cai, L., Zhang, Y., et al. (2014) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2014.04.008 · Cited by 54
The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases
Jung, T., Chung, W., & Oh, I. (2014) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2014.01.023 · Cited by 54
Spinal Cord Penetration of Intrathecally Administered Cytarabine and Methotrexate: A Quantitative Autoradiographic Study
Burch, P. A., Grossman, S. A., & Reinhard, C. S. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.15.1211 · Cited by 54
Diagnostic significance of cerebrospinal fluid EGFR mutation analysis for leptomeningeal metastasis in non-small-cell lung cancer patients harboring an active EGFR mutation following gefitinib therapy failure
Sasaki, S., Yoshioka, Y., Ko, R., Katsura, Y., Namba, Y., Shukuya, T., Kido, K., Iwakami, S., Tominaga, S., & Takahashi, K. (2015) · Respiratory Investigation · doi:10.1016/j.resinv.2015.07.001 · Cited by 53
Diagnostic Accuracy of PET, SPECT, and Arterial Spin-Labeling in Differentiating Tumor Recurrence from Necrosis in Cerebral Metastasis after Stereotactic Radiosurgery
Lai, G., Mahadevan, A., Hackney, D. B., et al. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4475 · Cited by 53
CellSearch® technology applied to the detection and quantification of tumor cells in CSF of patients with lung cancer leptomeningeal metastasis
Tu, Q., Wu, X., Rhun, É. L., Blonski, M., Wittwer, B., Taillandier, L., Bittencourt, M. D. C., & Faure, G. C. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.09.008 · Cited by 52
Selenium and glutathione peroxidase levels in patients with epidermoid carcinoma of the oral cavity and oropharynx
Goodwin, W. J., Lane, H. W., Bradford, K., Marshall, M. V., Griffin, A. C., Geopfert, H., & Jesse, R. H. (1983) · Cancer · doi:10.1002/1097-0142(19830101)51:1 · Cited by 52
Melanoma in the brain
Gibney, G. T., Forsyth, P. A., & Sondak, V. K. (2012) · Melanoma Research · doi:10.1097/cmr.0b013e328352dbef · Cited by 49
Detection of Epithelial Growth Factor Receptor Mutations in Cerebrospinal Fluid from Patients with Lung Adenocarcinoma Suspected of Neoplastic Meningitis
Shingyoji, M., Kageyama, H., Sakaida, T., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318219aaae · Cited by 49
Ipilimumab in Melanoma Patients with Brain Metastasis: A Retrospective Multicentre Evaluation of Thirty-eight Patients
Konstantinou, M., Dutriaux, C., Gaudy‐Marqueste, C., Mortier, L., Bédane, C., Girard, C., Thellier, S., Jouary, T., Grob, J., Richard, M. A., et al. (2014) · Acta Dermato Venereologica · doi:10.2340/00015555-1654 · Cited by 44
Activity of trastuzumab-emtansine (TDM1) in HER2-positive breast cancer brain metastases: A case series
Keith, K., Lee, Y. Z., Ewend, M. G., Zagar, T. M., & Anders, C. K. (2016) · Cancer Treatment Communications · doi:10.1016/j.ctrc.2016.03.005 · Cited by 44
Awake Craniotomy for Resection of Brain Metastases: A Systematic Review
Chua, T. H., See, A. A. Q., Ang, B. T., & King, N. K. K. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.08.243 · Cited by 44
Neoplastic Meningitis from Solid Tumors: New Diagnostic and Therapeutic Approaches
Lombardi, G., Zustovich, F., Farina, P., Puppa, A. D., Manara, R., Cecchin, D., Brunello, A., Cappetta, A., & Zagonel, V. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0101 · Cited by 43
Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions
Lee, D., Lee, K.-H., Kim, J. H., & Keam, B. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071074 · Cited by 41
Interval Change in Diffusion and Perfusion MRI Parameters for the Assessment of Pseudoprogression in Cerebral Metastases Treated With Stereotactic Radiation
Knitter, J. R., Erly, W. K., Stea, B., Lemole, G. M., Germano, I. M., Doshi, A. H., & Nael, K. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.17.18890 · Cited by 41
Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients
Zaïri, F., Rhun, É. L., Bertrand, N., Boulanger, T., Taillibert, S., Aboukaïs, R., Assaker, R., & Chamberlain, M. C. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1842-x · Cited by 40
Self-citation
Control of brain metastases from radioresistant tumors treated by stereotactic radiosurgery
Yaeh, A. M., Nanda, T., Jani, A., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1871-5 · Cited by 40
Role of ventriculoperitoneal shunting in patients with neoplasms of the central nervous system: An analysis of 59 cases
Nigim, F., Critchlow, J. F., & Kasper, E. M. (2015) · Molecular and Clinical Oncology · doi:10.3892/mco.2015.627 · Cited by 40
Surgical Ventricular Entry is a Key Risk Factor for Leptomeningeal Metastasis of High Grade Gliomas
Roelz, R., Reinacher, P. C., Jabbarli, R., Kraeutle, R., Hippchen, B., Egger, K. E., Weyerbrock, A., & Machein, M. R. (2015) · Scientific Reports · doi:10.1038/srep17758 · Cited by 40
Neoplastic meningitis
Chamberlain, M. C., & Johnston, S. K. (2009) · Cancer · doi:10.1002/cncr.24210 · Cited by 35
Is 5-ALA fluorescence of cerebral metastases a prognostic factor for local recurrence and overall survival?
Kamp, M. A., Munoz‐Bendix, C., Mijderwijk, H.-J., Turowski, B., Dibué, M., von Saß, C., Cornelius, J. F., Steiger, H., Rapp, M., & Sabel, M. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-03066-y · Cited by 33
Intravenous thiotepa for treatment of breast cancer-related leptomeningeal carcinomatosis: case series
Chahal, J., Stopeck, A., Clarke, K., Livingston, R. B., & Chalasani, P. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2259-1 · Cited by 31
Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients—A Systematic Review
Dudani, S., Mazzarello, S., Hilton, J. F., Hutton, B., Vandermeer, L., Fernandes, R., Ibrahim, M. F. K., Smith, S. R., Majeed, H., Al-Baimani, K. S., et al. (2016) · Clinical Breast Cancer · doi:10.1016/j.clbc.2016.07.014 · Cited by 31
Prognostic factors and clinical features in patients with leptominengeal metastases from breast cancer: a single center experience
Meattini, I., Livi, L., Saieva, C., Franceschini, D., Marrazzo, L., Greto, D., Scotti, V., Scoccianti, S., Paiar, F., Bordi, L., et al. (2012) · Journal of Chemotherapy · doi:10.1179/1973947812y.0000000034 · Cited by 30
Ventriculolumbar Perfusion Chemotherapy With Methotrexate for Treating Leptomeningeal Carcinomatosis: A Phase II Study
Gwak, H., Joo, J., Shin, S.-H., et al. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0199 · Cited by 29
Impact of Multimodality Approach for Patients with Leptomeningeal Metastases from Solid Tumors
Kwon, J., Chie, E. K., Kim, K., et al. (2014) · Journal of Korean Medical Science · doi:10.3346/jkms.2014.29.8.1094 · Cited by 29
Effect of Imaging Time in the Magnetic Resonance Detection of Intracerebral Metastases Using Single Dose Gadobutrol
Jeon, J. Y., Choi, J. W., Roh, H. G., et al. (2014) · Korean Journal of Radiology · doi:10.3348/kjr.2014.15.1.145 · Cited by 28
Stereotactic catheter placement for Ommaya reservoirs
Kennedy, B. C., Brown, L. T., Komotar, R. J., & McKhann, G. M. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.11.005 · Cited by 28
Image Guidance for Placement of Ommaya Reservoirs: Comparison of Fluoroscopy and Frameless Stereotactic Navigation in 145 Patients
Morgenstern, P. F., Connors, S. W., Reiner, A. S., et al. (2016) · World Neurosurgery · doi:10.1016/j.wneu.2016.04.090 · Cited by 28
Diagnostic value of 18F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site
Wolpert, F., Weller, M., Berghoff, A. S., Rushing, E. J., Füreder, L. M., Petyt, G., Leske, H., Andratschke, N. H., Regli, L., Neidert, M. C., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.03.010 · Cited by 28
Self-citation
Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue
Park, I. H., Kwon, Y., Ro, J. Y., Lee, K. S., & Ro, J. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0627-3 · Cited by 26
Meninges in cancer imaging
Mahendru, G. (2009) · Cancer Imaging · doi:10.1102/1470-7330.2009.9004 · Cited by 24
Novel method for the detection and quantification of malignant cells in the CSF of patients with leptomeningeal metastasis of lung cancer
Ma, C., Lv, Y., Jiang, R., et al. (2015) · Oncology Letters · doi:10.3892/ol.2015.3971 · Cited by 24
Vemurafenib in the French temporary authorization for use metastatic melanoma cohort
Fennira, F., Pagès, C., Schneider, P., et al. (2013) · Melanoma Research · doi:10.1097/cmr.0000000000000034 · Cited by 22
Cerebral Distribution of Immunoconjugate after Treatment for Neoplastic Meningitis Using an Intrathecal Radiolabeled Monoclonal Antibody
Benjamin, J. C., Moss, T. J. M., Mosely, R. P., et al. (1989) · Neurosurgery · doi:10.1227/00006123-198908000-00015 · Cited by 20
Two cases of leptomeningeal metastases from lung adenocarcinoma which progressed during gefitinib therapy but responded to erlotinib
Tetsumoto, S., Osa, A., Kijima, T., Minami, T., Hirata, H., Takahashi, R., Kuhara, H., Nagatomo, I., Takeda, Y., Kida, H., et al. (2011) · International Journal of Clinical Oncology · doi:10.1007/s10147-011-0256-9 · Cited by 19
Palliative lumboperitoneal shunt for leptomeningeal metastasis–related hydrocephalus: A case series
Yamashiro, S., Hitoshi, Y., Tajiri, S., et al. (2016) · Palliative Medicine · doi:10.1177/0269216316649128 · Cited by 19
Thinprep plus Papanicolaou Stain Method Is More Sensitive than Cytospin-Coupled Wright Giems Stain Method in Cerebrospinal Fluid Cytology for Diagnosis of Leptomeningeal Metastasis from Solid Tumors
Pan, Z., Yang, G., Wang, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122016 · Cited by 18
Gamma Knife radiosurgery for cystic brain metastases
Lee, S. R., Oh, J. Y., & Kim, S.-H. (2015) · British Journal of Neurosurgery · doi:10.3109/02688697.2015.1039489 · Cited by 17
Cerebral distribution of immunoconjugate after treatment for neoplastic meningitis using an intrathecal radiolabeled monoclonal antibody
Benjamin, J. C., Moss, T. J. M., Moseley, R. P., et al. (1989) · Neurosurgery · doi:10.1097/00006123-198908000-00015 · Cited by 17

Flagged first, then by citations

Sorted by citations

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Weller, M., van den Bent, M., Preusser, M., Le Rhun, E., Tonn, J. C., Minniti, G., Bendszus, M., Balana, C., Chinot, O., Dirven, L., et al. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00447-z · Cited by 2,048
Self-citation
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
Cardoso, F., Paluch-Shimon, S., Senkus, E., Curigliano, G., Aapro, M. S., André, F., Barrios, C. H., Bergh, J., Bhattacharyya, G. S., Biganzoli, L., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.09.010 · Cited by 1,369
“The EANO-ESMO CPG recommends considering focal RT for circumscribed, notably symptomatic lesions, andwhole-brain RT (WBRT) for extensive nodular or symptomatic linear LMD.101 The use of intrathecal therapy is controversial.”
BackgroundMethodInfluential
Leptomeningeal carcinomatosis in patients with breast cancer
Franzoi, M. A., & Hortobagyi, G. N. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.01.020 · Cited by 149
How we treat patients with leptomeningeal metastases
Le Rhun, E., Preusser, M., van den Bent, M., Andratschke, N., & Weller, M. (2019) · ESMO Open · doi:10.1136/esmoopen-2019-000507 · Cited by 127
Self-citation
Treatments on the Horizon: Breast Cancer Patients with Central Nervous System Metastases
Kaplan, A., Li, M. J., & Malani, R. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01206-2 · Cited by 4

See all 637

Authors: Le Rhun, E., Weller, M., Brandsma, D., Van den Bent, M., de Azambuja, E., Henriksson, R., Boulanger, T., Peters, S., Watts, C., Wick, W., Wesseling, P., Rudà, R., & Preusser, M.
Affiliations: University Hospital Zurich (CH)
University of Zurich (CH)
Centre Oscar Lambret (FR)
University of Cambridge (GB)
German Cancer Research Center (DE)
University Medical Center Utrecht (NL)
Comprehensive Cancer Center Vienna (AT)
ORCID: Weller, M.
Brandsma, D.
Henriksson, R.
Peters, S.
Watts, C.
Wick, W.
Wesseling, P.
Rudà, R.
Preusser, M.
Venue: Annals of Oncology
Publisher: Elsevier BV
Published: 2017-07
Volume: 28
Issue: 11
Pages: iv84-iv99
ISSN: 0923-7534 (ISSN-L)
DOI: 10.1093/annonc/mdx221
OpenAlex: W2734482945
Cited by: 637
References: 203
Citations by year: 2026: 33 · 2025: 81 · 2024: 131 · 2023: 127 · 2022: 109 · 2021: 59 · 2020: 35 · 2019: 39 · 2018: 18 · 2017: 2
FWCI: 21.26
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 894 d)
Locations: Annals of Oncology (publishedVersion)
PubMed (publishedVersion)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
HAL (submittedVersion)
IRIS (submittedVersion)
Pure Amsterdam UMC (submittedVersion)
Radboud Repository (Radboud University) (submittedVersion)
SERVAL (Université de Lausanne) (submittedVersion)
Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
Data Archiving and Networked Services (DANS) (submittedVersion)
Zurich Open Repository and Archive (University of Zurich)
Funders: ESMO
Topics: Health Sciences › Medicine › Oncology › Brain Metastases and Treatment
Health Sciences › Medicine › Surgery › Management of metastatic bone disease
Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
Keywords: leptomeningeal metastasis, solid tumors, diagnosis, treatment, follow-up, subarachnoid space
MeSH terms: Follow-Up Studies, Humans, Medical Oncology, Meningeal Neoplasms, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks